Skip to Content
US Videos

Has Health-Care Reform Eroded Pharma's Economic Moat?

Pricing power may be diminished somewhat, but patent protections should continue to bolster big pharma's competitive advantage, says Morningstar's Damien Conover.

Jeremy Glaser: For Morningstar, I'm Jeremy Glaser.

Has health-care reform eroded pharma's moat? I'm here today with Damien Conover--he is associate director of pharmaceutical research at Morningstar--take a look at this question.